Protective Effect of BCG and Neutrophil-to-Lymphocyte Ratio on Latent Tuberculosis in End Stage Renal Disease

Overview

Journal Infect Dis Ther

Specialty Infectious Diseases

Date 2023 Jul 6

PMID 37410344

Authors

Ping-Huai Wang

Shu-Yung Lin

Hung-Hsiang Liou

Chien-Chia Chen

Chin-Chung Shu

Chih-Yuan Lee

Meng-Kun Tsai

Chong-Jen Yu

Affiliations

Soon will be listed here.

Abstract

Introduction: Bacillus Calmette-Guérin (BCG) vaccination has been reported to be protective against latent tuberculosis infection (LTBI) in the general population. The aim of this study was to investigate the protective effect of BCG vaccination against LTBI in adult patients with end-stage renal disease (ESRD) and renal transplants.

Methods: Patients aged ≥ 20 years with ESRD who received hemodialysis (HD), peritoneal dialysis (PD) or kidney transplant were enrolled from January 2012 to December 2019 at a medical center and a regional hemodialysis center. Patients with active tuberculosis (TB), previously treated TB, active immunosuppressant therapy or human immunodeficiency virus infection were excluded. LTBI status was determined by QuantiFERON-TB Gold In-tube (QFT-GIT).

Results: After the exclusion of indeterminate results of QFT-GIT, 517 participants were enrolled and 97 (18.8%) were identified as having LTBI. Participants with LTBI were older (55.1 ± 11.4 vs. 48.5 ± 14.6 years, p < 0.001) and had a significantly higher proportion receiving HD than those without LTBI (70.1% vs. 56.7%, p = 0.001). The percentage with BCG scars was higher in the non-LTBI group than in the LTBI group (94.8% vs. 81.4%, p < 0.001), whereas the neutrophil-to-lymphocyte ratio (NLR) (≥ 2.68) was significantly higher in the LTBI group (62.8% vs. 45.5%, p = 0.02). By multivariate logistic regression analysis, presence of BCG scar and high NLR were independent protective factors against LTBI [adjusted OR: 0.19 (0.063-0.58, p = 0.001) and 0.50 (0.28-0.89, p = 0.02)].

Conclusion: The prevalence of LTBI was as high as 18.8% in patients with end-stage kidney disease or kidney transplant. BCG vaccination and high NLR might have protective effects against LTBI in patients with renal failure or transplant.

Citing Articles

Neutrophil-to-lymphocyte ratio and its association with latent tuberculosis infection and all-cause mortality in the US adult population: a cohort study from NHANES 2011-2012.

Huang Y, Ao T, Zhen P, Hu M Front Nutr. 2024; 11:1467824.

PMID: 39421611 PMC: 11484257. DOI: 10.3389/fnut.2024.1467824.

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates.

Zhou F, Zhang D Front Immunol. 2023; 14:1238649.

PMID: 38022657 PMC: 10652786. DOI: 10.3389/fimmu.2023.1238649.

References

Song M, Graubard B, Rabkin C, Engels E . Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep. 2021; 11(1):464. PMC: 7801737. DOI: 10.1038/s41598-020-79431-7. View

Rani S, Vijayalakshmi V, Sunil K, Lakshmi K, Suman L, Murthy K . Cell mediated immunity in children with scar-failure following BCG vaccination. Indian Pediatr. 1998; 35(2):123-7. View

Shu C, Hsu C, Lee C, Wang J, Wu V, Yang F . Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study. PLoS One. 2015; 10(4):e0124104. PMC: 4412816. DOI: 10.1371/journal.pone.0124104. View

Abubakar I, Drobniewski F, Southern J, Sitch A, Jackson C, Lipman M . Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. Lancet Infect Dis. 2018; 18(10):1077-1087. PMC: 6192014. DOI: 10.1016/S1473-3099(18)30355-4. View

Dow C, Kidess L . BCG Vaccine-The Road Not Taken. Microorganisms. 2022; 10(10). PMC: 9609351. DOI: 10.3390/microorganisms10101919. View

Trentini M, de Oliveira F, Kipnis A, Junqueira-Kipnis A . The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis. Front Microbiol. 2016; 7:898. PMC: 4901074. DOI: 10.3389/fmicb.2016.00898. View

Eum S, Kong J, Hong M, Lee Y, Kim J, Hwang S . Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2009; 137(1):122-8. PMC: 2803122. DOI: 10.1378/chest.09-0903. View

Michelsen S, Soborg B, Koch A, Carstensen L, Hoff S, Agger E . The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland. Thorax. 2014; 69(9):851-6. DOI: 10.1136/thoraxjnl-2014-205688. View

Ulusal Okyay G, Inal S, Onec K, Er R, Pasaoglu O, Pasaoglu H . Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2012; 35(1):29-36. DOI: 10.3109/0886022X.2012.734429. View

10.

Tuominen J, TALA E . Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence. Am J Respir Crit Care Med. 1998; 157(4 Pt 1):1324-7. DOI: 10.1164/ajrccm.157.4.9706037. View

11.

Kaufmann S . Robert Koch, the Nobel Prize, and the ongoing threat of tuberculosis. N Engl J Med. 2005; 353(23):2423-6. DOI: 10.1056/NEJMp058131. View

12.

Lin C, Kuo S, Hsieh M, Ho S, Su I, Lin S . Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open. 2019; 9(10):e029948. PMC: 6830704. DOI: 10.1136/bmjopen-2019-029948. View

13.

Sepulveda R, Parcha C, Sorensen R . Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile. Tuber Lung Dis. 1992; 73(6):372-7. DOI: 10.1016/0962-8479(92)90043-J. View

14.

Rodrigues L, Diwan V, Wheeler J . Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993; 22(6):1154-8. DOI: 10.1093/ije/22.6.1154. View

15.

Ulrichs T, Kaufmann S . New insights into the function of granulomas in human tuberculosis. J Pathol. 2005; 208(2):261-9. DOI: 10.1002/path.1906. View

16.

Forget P, Khalifa C, Defour J, Latinne D, Van Pel M, De Kock M . What is the normal value of the neutrophil-to-lymphocyte ratio?. BMC Res Notes. 2017; 10(1):12. PMC: 5217256. DOI: 10.1186/s13104-016-2335-5. View

17.

Poyntz H, Stylianou E, Griffiths K, Marsay L, Checkley A, McShane H . Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb). 2014; 94(3):226-37. PMC: 4066954. DOI: 10.1016/j.tube.2013.12.006. View

18.

Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4):367-416. DOI: 10.1164/rccm.200604-571ST. View

19.

Blomgran R, Ernst J . Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol. 2011; 186(12):7110-9. PMC: 3376160. DOI: 10.4049/jimmunol.1100001. View

20.

Martinez L, Cords O, Liu Q, Acuna-Villaorduna C, Bonnet M, Fox G . Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022; 10(9):e1307-e1316. PMC: 10406427. DOI: 10.1016/S2214-109X(22)00283-2. View